We are live on ! Find out more
SWTX

SpringWorks Therapeutics
SWTX

Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of SWTX yet.

SWTX Hedge Fund Activity: Q1 2026 in Review

1 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q1 2026, worth a combined $47 — down 100% from $2.18M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of SWTX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was DekaBank Deutsche Girozentrale, exiting entirely with an estimated $2.18M sold.

  • 1 institutional investor held SpringWorks Therapeutics (SWTX) as of Q1 2026, down from 2 in Q4 2025.
  • Funds reported $47 of SpringWorks Therapeutics stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new SpringWorks Therapeutics positions in Q1 2026 and 1 closed out, a net change of -1 holder.
  • The largest SpringWorks Therapeutics seller in Q1 2026 was DekaBank Deutsche Girozentrale, an estimated $2.18M sold.

Based on aggregated 13F filings for Q1 2026.